Breaking Judge Pauses Order for Trump’s Financial Records in BBC Defamation Case Midlife Health Habits Linked to Extended Dementia-Free Years, Study Finds Raiders Practice Sees On-Field Altercation Between Kirk Cousins and Maxx Crosby Senate Confirms Cameron Hamilton as FEMA Head Amid Agency Challenges James Harden’s Gun Charge Dismissed in Texas After Program Completion

Friday August 7, 2026

Section

Channels

Press Release

Proformex Debuts Willow, Closing the Information Gap in Life Insurance and Annuities

Proformex · Jul 28

Press Release

DiligenceVault Launches DV Assist 2.0, Embedding Applied AI Across Institutional Diligence Workflows

DiligenceVault · Jul 28

Press Release

Cheech and Chong’s Global Holding Company Supports Bipartisan Effort Toward Responsible Federal Hemp Regulation

Cheech and Chong's Global Holding Company · Jul 28

Press Release

ESGold Receives Exploration Authorization From Québec Government and Continues to Advance Its Permitted Tailings Reprocessing Project

ESGold Corp · Jul 28

Press Release

Hubbell Reports Second Quarter 2026 Results

Hubbell Inc. · Jul 28

Press Release

The 20-Minute Payroll Myth: How Hemiton Global Eliminates the 11–13 Days of Hidden Payroll Work

Issuewire · Jul 28

Press Release

Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer

Kazia Therapeutics Ltd · Jul 28

Press Release

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O’Grady as Chief Executive Officer to Lead Strategic Growth

Nasus Pharma, Ltd. · Jul 28

Press Release

ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform

ZenaTech Inc. · Jul 28

Press Release

PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.

PMGC Holdings Inc. · Jul 28

Press Release

Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference

Plus Therapeutics Inc. · Jul 28

Press Release

Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026

Palvella Therapeutics Inc. · Jul 28

Press Release

Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

Dyne Therapeutics, Inc. · Jul 28

← Previous 1 … 1,377 1,378 1,379 … 1,440 Next →